Bank Of America Corp Biogen Inc. Call Options Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $101 Million - $128 Million	-477,000 Reduced 96.79%	15,800 $3.41 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $98.4 Million - $118 Million	441,900 Added 868.17%	492,800 $128 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $59.1 Million - $68.3 Million	-214,800 Reduced 80.84%	50,900 $14.5 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $67.7 Million - $77.1 Million	263,800 Added 13884.21%	265,700 $73.9 Million
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $9.67 Million - $11.7 Million	-38,300 Reduced 95.27%	1,900 $526,000

Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $525,663 - $724,842	2,700 Added 7.2%	40,200 $10.7 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $7.88 Million - $9.37 Million	-42,000 Reduced 52.83%	37,500 $7.65 Million
Q4 2021 Feb 08, 2022	SELL	$223.92 - $287.77 $24.9 Million - $32 Million	-111,200 Reduced 58.31%	79,500 $19.1 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $34.1 Million - $44.5 Million	120,600 Added 172.04%	190,700 $54 Million
Q2 2021 Sep 13, 2021	BUY	$259.0 - $414.71 $18.2 Million - $29.1 Million	70,100 New	70,100 $24.3 Million

1,046

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.